Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc. (SION) Insider Trading
Directors, officers and holders of more than 10% of SION report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 284 transactions on file: 0 with code P, 23 with code S and 27 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | A Award | 103,140 | Not measured | Not measured |
| Sep 17, 2026 | Cloonan Michael | President & CEO | A Award | 109,025 | Not measured | Not measured |
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | S Sale | 3,415,011 | $6.32 | $21,582,870 |
| Sep 17, 2026 | Cloonan Michael | President & CEO | D Disposition | 436,100 | Not measured | Not measured |
| Sep 17, 2026 | Cloonan Michael | President & CEO | A Award | 436,100 | Not measured | Not measured |
| Sep 17, 2026 | McKee Charlotte | CMO and Head of R&D | A Award | 155,700 | Not measured | Not measured |
| Sep 17, 2026 | Ridloff Elena | CFO and CBO | A Award | 47,268 | Not measured | Not measured |
| Sep 17, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | D Disposition | 103,140 | Not measured | Not measured |
| Sep 17, 2026 | McKee Charlotte | CMO and Head of R&D | A Award | 50,000 | Not measured | Not measured |
| Sep 17, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | A Award | 28,133 | Not measured | Not measured |
| Sep 17, 2026 | McKee Charlotte | CMO and Head of R&D | A Award | 50,000 | Not measured | Not measured |
| Sep 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | S Sale | 33,800 | $7.46 | $252,148 |
| Sep 17, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | A Award | 28,132 | Not measured | Not measured |
| Sep 17, 2026 | Ridloff Elena | CFO and CBO | A Award | 165,440 | Not measured | Not measured |
| Sep 17, 2026 | McKee Charlotte | CMO and Head of R&D | D Disposition | 155,700 | Not measured | Not measured |
| Sep 17, 2026 | Ridloff Elena | CFO and CBO | D Disposition | 165,440 | Not measured | Not measured |
| Sep 17, 2026 | Ridloff Elena | CFO and CBO | A Award | 47,269 | Not measured | Not measured |
| Sep 17, 2026 | Cloonan Michael | President & CEO | A Award | 109,025 | Not measured | Not measured |
| Jul 7, 2026 | Thompson Peter A. | Director | S Sale | 85,918 | $44.86 | $3,854,281 |
| Jul 7, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 85,918 | $44.86 | $3,854,281 |
| Jul 6, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | M Exercise | 10,250 | Not measured | Not measured |
| Jul 6, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | M Exercise | 10,250 | $6.11 | $62,628 |
| Jul 6, 2026 | Fitzpatrick Jennifer | CLO and Head of Program Mgmt. | S Sale | 10,250 | $43.60 | $446,862 |
| Jun 30, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 115,844 | $45.50 | $5,270,902 |
| Jun 30, 2026 | Thompson Peter A. | Director | S Sale | 115,844 | $45.50 | $5,270,902 |
| Jun 17, 2026 | Resnick Joshua | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Booth Bruce | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Ruddy Marcella K. | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Stelzer Laurie | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Thompson Peter A. | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Fleming Harold Edward | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Clancy Paul J | Director | A Award | 17,340 | Not measured | Not measured |
| Jun 17, 2026 | Viney Joanne L. | Director | A Award | 17,340 | Not measured | Not measured |
| May 27, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 101 | $44.49 | $4,493 |
| May 27, 2026 | Thompson Peter A. | Director | S Sale | 101 | $44.49 | $4,493 |
| May 11, 2026 | Thompson Peter A. | Director | S Sale | 184,639 | $46.22 | $8,534,015 |
| May 11, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 184,639 | $46.22 | $8,534,015 |
| May 8, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 59,767 | $44.58 | $2,664,413 |
| May 8, 2026 | Thompson Peter A. | Director | S Sale | 59,767 | $44.58 | $2,664,413 |
| May 7, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 48,546 | $44.61 | $2,165,637 |
| May 7, 2026 | Thompson Peter A. | Director | S Sale | 48,546 | $44.61 | $2,165,637 |
| Apr 18, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 2,948 | $44.52 | $131,245 |
| Apr 18, 2026 | Thompson Peter A. | Director | S Sale | 2,948 | $44.52 | $131,245 |
| Apr 17, 2026 | Thompson Peter A. | Director | S Sale | 52,397 | $44.68 | $2,341,098 |
| Apr 17, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 52,397 | $44.68 | $2,341,098 |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 226,906 | $45.34 | $10,287,918 |
| Apr 16, 2026 | Thompson Peter A. | Director | S Sale | 226,906 | $45.34 | $10,287,918 |
| Apr 15, 2026 | Thompson Peter A. | Director | S Sale | 235,863 | $44.64 | $10,528,924 |
| Apr 15, 2026 | ORBIMED ADVISORS LLC | Director | S Sale | 235,863 | $44.64 | $10,528,924 |
The full Form 4 history is on the SION company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.